Dana Farber Cancer Institute SC-12

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

ALK-positive Non-small Cell Lung Cancer

Studies at this site

• A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges — Completed